Showing results (151-160 of 244) with videos related to

Sort By:
Pageof 25
Antioxidants & Redox Signaling|December 11, 2012
Does NADPH oxidase deficiency cause artery dilatation in humans?Lorenzo Loffredo, Roberto Carnevale, Valerio Sanguigni, et al.
BMC Immunology|February 8, 2008
Screening of functional and positional candidate genes in families with common variable immunodeficiencyUlrich Salzer, Carla Neumann, Jens Thiel, et al.
Molecular Immunology|May 5, 2009
Molecular characterization of a large cohort of patients with Chronic Granulomatous Disease and identification of novel CYBB mutations: an Italian multicenter studyGigliola Di Matteo, Lucia Giordani, Andrea Finocchi, et al.
Expert Review of Clinical Immunology|February 25, 2016
Cohort of Iranian Patients with Congenital Agammaglobulinemia: Mutation Analysis and Novel Gene DefectsHassan Abolhassani, Massimiliano Vitali, Vassilios Lougaris, et al.
Pediatrics|September 30, 2009
Differentiating PFAPA syndrome from monogenic periodic feversMarco Gattorno, Roberta Caorsi, Antonella Meini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2012
A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasiaRaffaella Zannolli, Sabrina Buoni, Gianni Betti, et al.
Journal of Clinical Immunology|November 21, 2021
Immunological Evaluation of Patients Affected with Jacobsen Syndrome Reveals Profound Not Age-Related Lymphocyte AlterationsManuela Baronio, Francesco Saettini, Luisa Gazzurelli, et al.
Oncotarget|February 11, 2017
BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotypeRoberta Zuntini, Laura Cortesi, Daniele Calistri, et al.
Arthritis and Rheumatism|March 2, 2006
Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implicationsAndrea D'Osualdo, Francesca Ferlito, Ignazia Prigione, et al.
The Journal of Allergy and Clinical Immunology|March 27, 2019
Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficienciesCinzia Milito, Federica Pulvirenti, Francesco Cinetto, et al.
Pageof 25